Accounting for Product Impact in the Pharmaceuticals Industry
22 Pages Posted: 2 Jul 2021
Date Written: June 30, 2021
We apply the product impact measurement framework of the Impact-Weighted Accounts Initiative (IWAI) in two competitor companies within the pharmaceuticals industry. We design a monetization methodology that allows us to calculate monetary impact estimates of accessible product provision and efficacy, among other factors. Our results indicate substantial differences in the impact that competitors have through their products. These differences demonstrate how impact reflects corporate strategy and informs decision-making on industry-specific areas.
Suggested Citation: Suggested Citation
Rischbieth, Amanda and Serafeim, George and Trinh, Katie, Accounting for Product Impact in the Pharmaceuticals Industry (June 30, 2021). Harvard Business School Accounting & Management Unit Working Paper No. 21-139, Available at SSRN: https://ssrn.com/abstract=3877517 or http://dx.doi.org/10.2139/ssrn.3877517
Do you have a job opening that you would like to promote on SSRN?
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.